1. Home
  2. INKT vs COCH Comparison

INKT vs COCH Comparison

Compare INKT & COCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MiNK Therapeutics Inc.

INKT

MiNK Therapeutics Inc.

HOLD

Current Price

$12.49

Market Cap

70.6M

Sector

Health Care

ML Signal

HOLD

Logo Envoy Medical Inc.

COCH

Envoy Medical Inc.

HOLD

Current Price

$0.64

Market Cap

49.7M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
INKT
COCH
Founded
2017
1995
Country
United States
United States
Employees
N/A
47
Industry
Medicinal Chemicals and Botanical Products
Blank Checks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
70.6M
49.7M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
INKT
COCH
Price
$12.49
$0.64
Analyst Decision
Buy
Strong Buy
Analyst Count
2
2
Target Price
$35.00
$6.00
AVG Volume (30 Days)
40.1K
123.9K
Earning Date
05-15-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$1.58
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.80
$0.36
52 Week High
$76.00
$1.89

Technical Indicators

Market Signals
Indicator
INKT
COCH
Relative Strength Index (RSI) 52.09 42.48
Support Level $10.79 $0.64
Resistance Level $12.55 $0.73
Average True Range (ATR) 1.00 0.04
MACD 0.05 -0.01
Stochastic Oscillator 51.64 28.24

Price Performance

Historical Comparison
INKT
COCH

About INKT MiNK Therapeutics Inc.

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development and manufacturing of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. iNKT cells offer distinct therapeutic advantages as a platform for allogeneic therapy in that the cells naturally home to tissues, aid clearance of tumors and infected cells, and suppress graft-versus-host-disease. Its product candidate, agenT-797, is an off-the-shelf, allogeneic, native iNKT cell therapy. It operates its business in single segment.

About COCH Envoy Medical Inc.

Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing.

Share on Social Networks: